Heterocyclic Compounds, 3-Ring

"Heterocyclic Compounds, 3-Ring" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A class of heterocyclic compounds that include a three-ring fused structure. Both aromatic or non-aromatic ring structures are included in this category.

Descriptor ID	D006575
MeSH Number(s)	D03.633.300
Concept/Terms	Heterocyclic Compounds, 3-Ring Heterocyclic Compounds, 3-Ring 3-Ring Heterocyclic Compounds Heterocyclic Compounds, 3 Ring Heterocyclic Cpds, 3 Ring Fused Heterocyclic Compounds, Three-Ring Fused Heterocyclic Compounds, Three Ring Three Ring Heterocyclic Compounds

Below are MeSH descriptors whose meaning is more general than "Heterocyclic Compounds, 3-Ring".

Chemicals and Drugs [D]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, Fused-Ring [D03.633]
Heterocyclic Compounds, 3-Ring [D03.633.300]

Below are MeSH descriptors whose meaning is related to "Heterocyclic Compounds, 3-Ring".

Below are MeSH descriptors whose meaning is more specific than "Heterocyclic Compounds, 3-Ring".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Heterocyclic Compounds, 3-Ring" by people in this website by year, and whether "Heterocyclic Compounds, 3-Ring" was a major or minor topic of these publications.

Bar chart showing 5 publications over 3 distinct years, with a maximum of 3 publications in 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2010	1	0	1
2021	1	2	3
2022	0	1	1

Below are the most recent publications written about "Heterocyclic Compounds, 3-Ring" by people in Profiles.

Abrams EJ, Jao J, Madlala HP, Zerbe A, Catalano P, Gerschenson M, Goedecke JH, Gomba Y, Josefson J, Kurland IJ, Legbedze J, McComsey GA, Matyesini S, Mukonda E, Robinson D, Myer L. An observational cohort study to investigate the impact of dolutegravir in pregnancy and its obesogenic effects on the metabolic health of women living with HIV and their children: Study protocol. PLoS One. 2024; 19(8):e0307296.

View in: PubMed
Mullen M, Yang F, Cao J, Cao Y, Liu X, Lee GY, Li T, Yao W, Yang Z, Zhang J, Johnson K, Aikhionbare F, Chen Y, Gao X, Wang D, Ding X, Green HN, Liu X, Yao X. Syntelin inhibits triple-negative breast cancer cell proliferation and metastasis. J Mol Cell Biol. 2022 01 21; 13(11):834-837.

View in: PubMed
Weichseldorfer M, Affram Y, Heredia A, Rikhtegaran-Tehrani Z, Sajadi MM, Williams SP, Tagaya Y, Benedetti F, Ramadhani HO, Denaro F, Munawwar A, Bryant J, Zella D, Reitz M, Romerio F, Latinovic OS. Combined cART including Tenofovir Disoproxil, Emtricitabine, and Dolutegravir has potent therapeutic effects in HIV-1 infected humanized mice. J Transl Med. 2021 10 30; 19(1):453.

View in: PubMed
Gambardella A, Licata G, Calabrese G, De Rosa A, Alfano R, Argenziano G. Dual Efficacy of Upadacitinib in 2 Patients With Concomitant Severe Atopic Dermatitis and Alopecia Areata. Dermatitis. 2021 Oct 01; 32(1S):e85-e86.

View in: PubMed
Mmasa KN, Powis K, Sun S, Makhema J, Mmalane M, Kgole S, Masasa G, Moyo S, Gerschenson M, Mohammed T, Legbedze J, Abrams EJ, Kurland IJ, Geffner ME, Jao J. Gestational diabetes in women living with HIV in Botswana: lower rates with dolutegravir- than with efavirenz-based antiretroviral therapy. HIV Med. 2021 09; 22(8):715-722.

View in: PubMed
Ding X, Yan F, Yao P, Yang Z, Wan W, Wang X, Liu J, Gao X, Abrieu A, Zhu T, Zhang J, Dou Z, Yao X. Probing CENP-E function in chromosome dynamics using small molecule inhibitor syntelin. Cell Res. 2010 Dec; 20(12):1386-9.

View in: PubMed

People

Explore

Similar Concepts

Top Journals